<?xml version="1.0" encoding="UTF-8"?>
<p id="p0035">Globally, chronic infection with the HBV is an important cause of liver-related morbidity and mortality due to its widespread distribution. An estimated 257 to 291 million people are chronically infected with HBV and are at risk of cirrhosis and hepatocellular carcinoma (HCC).
 <xref rid="bib1" ref-type="bibr">
  <sup>1</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib2" ref-type="bibr">
  <sup>2</sup>
 </xref> The proportion of cirrhosis attributable to HBV varies geographically according to HBV epidemiology, ranging from 6% in North America, to 6-21% in Latin America, 34â€“38% in sub-Saharan Africa, and 39% in East Asia.
 <xref rid="bib3" ref-type="bibr">
  <sup>3</sup>
 </xref> Worldwide, HBV is associated with a third of deaths from HCC.
 <xref rid="bib4" ref-type="bibr">
  <sup>4</sup>
 </xref>
</p>
